RE: Novacyt WINNING RACE for high speed virus test11 Feb 2020 12:24
HiberGene Diagnostics Announces Collaboration to Evaluate Near-Patient Coronavirus Test
Collaboration with Medcaptain Medical Technologies targets speedy validation of LAMP-based rapid molecular test for Coronavirus
Dublin, Ireland - 11th February 2020 - HiberGene Diagnostics ("HiberGene") today announces that they have expedited the design of a new, rapid near-patient molecular test for Novel Coronavirus 2019-nCoV. The Coronavirus test will undergo clinical evaluation in China in collaboration with HiberGene's local distribution partner, Medcaptain Medical Technologies ("Medcaptain"), based in Shenzhen, China.